Evidence map›Paper›PMID 19573080›Full record

ArticleBritish journal of haematology2009

Common genetic variants in candidate genes and risk of familial lymphoid malignancies.

Xueying Sharon Liang, Neil Caporaso, Mary Lou McMaster, David Ng, Ola Landgren, Meredith Yeager, Stephen Chanock, Lynn R Goldin

Open access · bronzeAbstract read
In one paragraph

Article in British journal of haematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.Mediterranean journal of hematology and infectious diseases · 2014
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. TNF superfamily gene polymorphism as prognostic factor in early breast cancer.Journal of cancer research and clinical oncology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Xueying Sharon LiangGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892-7236, USA. liangx2@mail.nih.gov
Neil Caporaso
Mary Lou McMaster
David Ng
Ola Landgren
Meredith Yeager
Stephen Chanock
Lynn R Goldin
Division of Cancer Epidemiology and GeneticsNational Cancer Institute · UACenter for Cancer Research · USNational Cancer Institute · US

Funding

Family Studies ZIACP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$56.1M
Population based studiesZIABC011205 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LANDGREN, OLA · 2009 to 2014
$858k
Intramural NIH HHS ZIA CP004410
6 · The paper itself

Abstract

Familial aggregation, linkage and case-control studies support the role of germline genes in the aetiology of lymphoid malignancies. To further examine the role of genetic variation underlying susceptibility, we analysed 1536 single nucleotide polymorphisms in 152 genes involved in apoptosis, DNA repair, immune response and oxidative stress pathways among a unique sample of 165 unrelated familial cases including patients with chronic lymphocytic leukaemia (CLL), Waldenström macroglobulinaemia (WM) and Hodgkin lymphoma (HL), and 107 spouse controls. We confirmed previous studies showing a polymorphism in the IL10 promoter (rs1800890/-3575T>A) to be associated with non-Hodgkin lymphoma, as this allele was found to be associated with both CLL and WM. We also confirmed the role of IL6 variation to be associated with HL. Polymorphisms in TNFSF10 were associated with both CLL and WM. Future replication and functional studies are needed to clarify the role of these genetic variants. Finally, our data further support the close association of WM and CLL.

Indexed as

Polymorphism, Single NucleotideCase-Control StudiesCell Line, TumorGenetic VariationGenotypeHodgkin DiseaseHumansInterleukin-10Interleukin-6Leukemia, Lymphocytic, Chronic, B-CellLogistic ModelsLymphoproliferative DisordersOdds RatioPromoter Regions, GeneticRiskTNF-Related Apoptosis-Inducing LigandInterleukin-10Interleukin-6TNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Identifiers

PMID19573080
PMCPMC2890251
OpenAlexW2019239152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.